Nephrology

sponsor

Topics in Nephrology

Basic Science/Genetics

Chronic Dz/Renal Failure

Economics of Medicine

Fluids and Electrolytes

Glomerular/Tubular Dz

Hematology/Oncology

Pediatric Nephrology

Pharmacology/kinetics

Radiology/Diagnostics

Transplantation

Ureteral Disease

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Top Ten Searches

aldosteronism

contrast

dialysis

vitamin d

bicarbonate

arf

amyloidosis

hypocalcemia

renal artery

hus

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient
Urology, 10/12/09

Tollefson MK et al. – Surgical resection of RCC in transplant patients is associated with a low rate of progression, despite optimal immunosuppression. The authors recommend surgical resection of low–risk, organ–confined RCC without reduction in immunosuppression in patients with solid organ transplants.

<< Previous
Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin...

Next >>
Growth-plate cartilage in chronic renal failure

Today in Hematology/Oncology...keeping you current

Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09

A Randomized Controlled Study of Weekly and Biweekly Dosing of Epoetin Alfa in CKD Patients With Anemia
Clinical Journal of the American Society of Nephrology, 11/05/09

Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Annals of Oncology, 10/29/09

See All of Hematology/Oncology

Today in Transplantation...keeping you current

Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
Rheumatology International, 11/04/09

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial
American Journal of Kidney Diseases, 11/19/09

Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 10/30/09

See All of Transplantation

Article Search

Sponsor

Send this Summary to a Colleague